Dr. Gulnara Dzhaksybekova

Dr. Gulnara Dzhaksybekova is a consultant neurologist at Astana Medical University Teaching Hospital in Nur-Sultan — Kazakhstan's capital city and one of the country's most rapidly developing medical centers. With 16 years of neurology practice, Dr. Dzhaksybekova provides comprehensive neurological care to patients from across Kazakhstan, with particular expertise in stroke, multiple sclerosis, and epilepsy.

Her stroke neurology work is integrated into the hospital's stroke care pathway, providing rapid neurological assessment and IV thrombolysis for eligible acute ischemic stroke patients. She manages secondary stroke prevention programs addressing hypertension, dyslipidemia, and atrial fibrillation — the leading risk factors for stroke in Kazakhstan's population.

Her multiple sclerosis practice is particularly significant in Central Asia, where MS awareness and diagnostic access are developing. She diagnoses MS using McDonald criteria with MRI and CSF analysis and prescribes disease-modifying therapies including interferon-betas, glatiramer acetate, dimethyl fumarate, and high-efficacy options for appropriate patients. She runs a dedicated MS clinic at Astana Medical University Teaching Hospital.

For epilepsy, she performs and interprets EEG, manages antiseizure medications, and coordinates evaluation for drug-resistant cases. She is an Associate Professor at Astana Medical University and is committed to neurology education in Kazakhstan. She communicates in Kazakh, Russian, and English.

Dr. Dzhaksybekova obtained her MD from Astana Medical University and completed Neurology residency at Astana Medical University Teaching Hospital. She undertook advanced neurology training in Germany at the University Hospital of Cologne's neurology department, with subspecialty training in stroke and MS. She holds a PhD in Neurology from Astana Medical University and the FEAN (Fellow of the European Academy of Neurology) designation. She is an Associate Professor of Neurology at Astana Medical University.

Dr. Dzhaksybekova's neurology practice covers acute and chronic neurological disease. In acute stroke, she administers IV alteplase for eligible patients, interprets MRI diffusion-weighted imaging, and manages secondary prevention. In MS, she diagnoses using McDonald criteria and manages all approved disease-modifying therapies, monitoring patients on high-efficacy agents. For epilepsy, she performs EEG interpretation, prescribes and titrates antiseizure medications, and coordinates video-EEG for drug-resistant cases. She performs lumbar puncture for CSF analysis, EMG/NCS for peripheral neuropathy, and botulinum toxin for chronic migraine. She manages Parkinson's disease with dopaminergic pharmacotherapy.

Dr. Dzhaksybekova has published in the Kazakhstan Medical Journal and contributed to EAN registry data. She participates in the Kazakhstan Neurological Society and presents at the national neurology conference and EAN annual congress. She collaborates with German neurology centers through the established academic exchange.

Astana Medical University Teaching Hospital serves Kazakhstan's domestic population and receives referrals from neighboring Central Asian countries. Dr. Dzhaksybekova consults in Kazakh, Russian, and English. Video consultations are available for neurological second opinions and chronic disease management.

Dr. Dzhaksybekova has been recognized by the Kazakhstan Neurological Society for her contributions to MS awareness and stroke care in Kazakhstan. She is an Associate Professor at Astana Medical University and participates in EAN educational programs for the Central Asian region.